Oryzon Genomics (XMAD:ORY) Short Ratio


XMAD:ORY Oryzon Genomics SA XMAD:ORY
29 GF Score
Price €2.98
View Full Analysis

What is Oryzon Genomics Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XMAD:ORY
29GF Score
Oryzon Genomics SA XMAD:ORY
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oryzon Genomics Business Description

Other Exchanges ORYZF:USA0RDB:UKORN:Germany
Address Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
29GF Score

Get the complete analysis for XMAD:ORY

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.98
Price